National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 5) (PB 46 of 2017) (Cth)

PB 46 of 2017

National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 5)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated         27 June 2017

PENNY SHAKESPEARE

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment instrument – Pharmaceutical benefits – early supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical benefits – early supply) Amendment Instrument 2017 (No. 5)

(2)This Instrument may also be cited as PB 46 of 2017.

2          Commencement

This Instrument commences on 1 July 2017.

3          Amendment of PB 120 of 2015

Schedule 1 amends the National Health (Pharmaceutical benefits—early supply) Instrument 2015 (PB 120 of 2015).

Schedule 1        Amendments

1. Schedule 1, after entry for Adalimumab in the form Injection 40 mg in 0.8 mL pre‑filled pen [Maximum Quantity: 2;
   Number of Repeats: 5]

insert:

Adalimumab Injection 40 mg in 0.8 mL pre-filled pen, 4 20 1 5

1. Schedule 1, after entry for Pioglitazone

insert:

Pirfenidone Capsule 267 mg 20 270 5

1. Schedule 1, after entry for Rotigotine in the form Transdermal patch 13.5 mg

insert:

Rotigotine Transdermal patch 18 mg 20 28 5